F Dx Advisors, Inc. United Therapeutics Corp Transaction History

F Dx Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$101.14 - $118.31 $439,756 - $514,411	-4,348 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$107.21 - $151.94 $321 - $455	3 Added 0.07%	4,348 $489,000
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $43,044 - $54,914	-363 Reduced 7.71%	4,345 $643,000
Q3 2017 Nov 03, 2017	SELL	$114.6 - $136.81 $19,252 - $22,984	-168 Reduced 3.45%	4,708 $552,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,876	4,876 $633,000

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.